CN Foundry designed the brand mark for the Innovative Medicines Manufacturing Institute (IMMI), a public-private partnership comprising universities, tech businesses and bio/pharma companies. IMMI envisions speeding the development of advanced manufacturing solutions for America’s drug industry. The new technologies will revolutionize production of drugs in three categories of medicines: small molecule pharmaceuticals, large molecule/biologic and cell and gene-based biopharmaceuticals.

Comments are closed.